v3 Template
A

Avextra AG

Pharmaceuticals / Medical Cannabis
Founded
--
Employees
--
Total Funding
$40.0M
Funding Rounds
2
Last Funding
2024-02-07

About Avextra AG

Avextra is a German company focused on the development and production of cannabis-based medicines. Their mission is to create high-quality, evidence-based pharmaceutical products by controlling the entire value chain from cultivation in Portugal to GMP-certified manufacturing in Germany, aiming to improve patient outcomes through research and innovation.

Products & Services

Cannabis-based Medicines:Pharmaceutical products derived from medical cannabis, designed to alleviate symptoms and improve patient quality of life, produced under strict quality standards.
Extracts and Dronabinol:Specialized cannabis extracts and Dronabinol formulations for medical use, focusing on consistency and efficacy.
Avextra THC/CBD Quick Test:A testing kit for pharmacists to ensure accurate identification and dosage of THC/CBD content in products.

Specialties

Cannabis-based Medicines Research and Development of Evidence-based Therapies GMP-certified Pharmaceutical Manufacturing Clinical Studies and Real-World Data Analysis Herbal Medicine Expertise (over 75 years of experience)

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Follow-on capital raise with Equity instruments and Convertible Loan Notes
T: -
FT: Follow-on capital raise with Equity instruments and Convertible Loan Notes
A: 21600000
MR: -
FA: above EUR 20 million
FAN: 21600000
D: 2024-02-07
FD: 2024-02-07
4 investors
2 RT: Convertible Loan Note
T: -
FT: Convertible Loan Note
A: 18360000
MR: -
FA: €17 million
FAN: 18360000
D: 2023-03-15
FD: 2023-03-15
3 investors
Follow-on capital raise with Equity instruments and Convertible Loan Notes Latest
2024-02-07
$21.6M
4 investors (Pro only)
Convertible Loan Note 2023-03-15
$18.4M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Avextra AG Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Pharmaceuticals / Medical Cannabis

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro